SDZNY Stock: Sandoz Group AG Stock Price, Analysis & Insights
Get live SDZNY stock price $82.18, comprehensive Sandoz Group AG stock analysis, charts, news, and expert forecast. Real-time SDZNY stock data and investment insights.
Loading chart data...
Sandoz Group AG (SDZNY) Overview
Sandoz Group AG (SDZNY) is a publicly traded company in the Healthcare sector , specifically within the Drug Manufacturers - Specialty & Generic industry . As of the latest trading session, SDZNY trades at $82.18 with a market capitalization of 35.56B . Over the past 52 weeks, SDZNY has traded between $51.72 and $94.15 , with the current price positioned at approximately 72% of this range . The...
Key Takeaways
- Operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic)
- Market cap: 35.56B
- Current price: $82.18
- 52-week range: $51.72 - $94.15
- P/E ratio: 39.32
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Sandoz Group AG operates as a global pharmaceutical enterprise, primarily focusing on the development, manufacturing, and commercialization of generic medicines and biosimilars. Their offerings include finished dosage forms of small molecule pharmace...
Company Information
- CEO
- Richard Saynor
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Employees
- 22049
Contact Information
- Website
- https://www.sandoz.com
- Address
- Suurstoffi 14
- Country
- CH
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Growth-oriented company with premium valuation (P/E: 39.3)
✓ Lower volatility stock (Beta: 0.53) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Sandoz Group AG shareholders
- ⚠Market volatility can significantly impact stock price, especially for mid-cap stocks
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Sandoz Group AG
- ⚠Investors should consider how Sandoz Group AG fits within their overall portfolio allocation
- ⚠Premium valuation (P/E: 39.3) requires strong growth to justify
Market Cap
35.56B
P/E Ratio (TTM)
39.32
Beta
0.53
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare SDZNY with peer companies:
- Price
- $10.16
- Market cap
- 39.93B
- Price
- $54.35
- Market cap
- 30.61B
- Price
- $4.51
- Market cap
- 39.78B
- Price
- $5.85
- Market cap
- 18.69B
- Price
- $64.00
- Market cap
- 33.70B
- Price
- $31.71
- Market cap
- 33.44B
- Price
- $25.99
- Market cap
- 25.24B
- Price
- $203.66
- Market cap
- 19.82B
- Price
- $30.34
- Market cap
- 35.33B
- Price
- $31.30
- Market cap
- 49.45B
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.